Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
ZVSA
$0.19
-40.51%
ZVSA
· ZyVersa Therapeutics, Inc.
$0.19
-0.13 (-40.51%)
At close · Jul 17
Return incl. dividend (before tax)
Going-concern doubt
— flagged May 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These uncertainties raise substantial doubt about our ability to continue as a going concern for 12 months after the issuance date of our financial statements.”View the 10-Q filed May 13, 2026
Market Cap
$833,880
Shares
8.10M
Volume · Jul 17
1.71M
Avg daily vol (3M)
5.63M
All webcasts
Earnings call · FY2024 Q3
ZyVersa Therapeutics, Inc. (ZVSA) Q3 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$2.43
Net income
-$2.40M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 14, 2024 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2024 · complete as-filed document